Viral Safety: Protecting your process from start to finish

Millipore Technical Publications

		EMD_PB3318EN00.pdf BR- PB3318EN00
Viral Safety: Protecting your process from start to finish
Lit No:	PB3318EN00
Year:	2012

As a drug manufacturer, you are required to ensure the viral safety of your biological therapeutic products. Regulatory guidance advocates virus control at various stages of the drug manufacturing process, directing that you:

Select and test source materials for the absence of virus
Test the capacity of the production process to remove or inactivate virus
Test the product at appropriate stages of production for detectable virus

Partnering with a company that can assist you through all of these critical steps is an
important factor.

Click the PDF above for the full document.